Edition:
United States

Check Cap Ltd (CHEK.OQ)

CHEK.OQ on NASDAQ Stock Exchange Capital Market

4.30USD
19 Jun 2018
Change (% chg)

-- (--)
Prev Close
$4.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
124,564
52-wk High
$24.00
52-wk Low
$3.30

Chart for

About

Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company's system consists of main components, such as ingestible... (more)

Overall

Beta: --
Market Cap(Mil.): $21.36
Shares Outstanding(Mil.): 5.01
Dividend: --
Yield (%): --

Financials

  CHEK.OQ Industry Sector
P/E (TTM): -- 29.73 33.88
EPS (TTM): -6.11 -- --
ROI: -150.00 13.68 13.21
ROE: -163.27 15.46 15.18

BRIEF-Check Cap Reports Qtrly Net Loss Per Ordinary Share $1.22

* CAP REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Apr 04 2018

BRIEF-Check-Cap Appoints Alex Ovadia As Chief Executive Officer

* CHECK CAP LTD - ALEX OVADIA SUCCEEDS WILLIAM DENSEL Source text for Eikon: Further company coverage:

Feb 26 2018

BRIEF-Check-Cap Receives CE Mark Approval For C-Scan

* CHECK-CAP RECEIVES CE MARK APPROVAL FOR C-SCAN® Source text for Eikon: Further company coverage:

Jan 10 2018

BRIEF-Check Cap Files Prospectus Relating To Resale Of Up To 1.7 Million Ordinary Shares

* CHECK CAP LTD FILES PROSPECTUS RELATING TO RESALE OF UP TO 1.7 MILLION ORDINARY SHARES - SEC FILING Source: (http://bit.ly/2DidLmo) Further company coverage:

Dec 20 2017

Earnings vs. Estimates